I’ve been saving up balloons, ticker tape, and confetti to use on a week of unalloyed good news, but it looks like I’m going to have to wait at least one more week. The NASDAQ Composite dropped -3.6% for the week, with the two biotech indices lopping off -2.8% and -5.4%.
Acting in sympathy with the majority of biotech stocks, many of the mid-Atlantic states on the East Coast are underwater this weekend, or at least rain, thanks to tropical storm Ophelia. The storm shares its name with the forlorn character who drowned in Shakespeare’s play, “Hamlet,” but I presume this is a coincidence.
The best performer for the week was INZY, +29% of original price, as it announced that it will host a virtual Investor and Analyst Event next Tuesday where it will produce interim data updates from ongoing Phase 1/2 trials, improving its position as the top YTD stock to +340%. Second Place SCLP.L (+25%), mostly from a pop on Tuesday, induced the CEO to “hail exciting high response rate to melanoma treatment” in an interview released Wednesday. The big loser for the week, NAUT, dropped -42%, giving back all of the big gain that took place in the closing minutes of last week’s trading, and removing it from the top five YTD performers list. The fifth worst stock, RVNC, dropped -20% for the week, mostly in the opening minutes of Tuesday’s trading, which in the following day resulted in a report in Investor's Business Daily: “… Revance Implodes…“ apparently because RVNC decided to cut the price of its Botulinin toxin product to be competitive with Botox.
The average portfolio dropped again, this week losing -$5.4k. Only a single portfolio was in the black for the week, A.J. MULLEN. Positions in both SCLP.L and MRTX brought in $5.4k, almost all of which was wiped out by loses in the remainder of the portfolio to give them a net profit of only $540. Third place for the week ERIKOTTO, -$980, was good enough to move past RKRW and take the second place spot YTD, only $5.1k behind first place ALONER.
Report Time Ranges
|
|
|
|
|
| From
| To
|
|
|
|
|
|
|
|
| Recent
| 9/15/2023
| 9/22/23
|
|
|
|
|
|
|
|
| YTD
| 12/31/2022
|
|
|
|
| Index Portfolios’ Performance
|
|
|
|
| Symbol
| Recent P/L
| Recent %
| YTDP/L
|
|
|
|
|
|
|
|
| ^IXIC
| -$4,743.98
| -3.6%
| $26,229.69
|
|
|
|
|
|
|
|
| ^NBI
| -$2,654.65
| -2.8%
| -$6,345.79
|
|
|
|
|
|
|
|
| ^SPSIBI
| -$5,027.42
| -5.4%
| -$12,105.37
|
|
|
|
| Share Performance
| Recent Performance
| YTD Performance
|
| Top Five
|
| Bottom Five
|
| Top Five
|
| Bottom 5
| Symbol
| P/L / Initial Price
| Symbol
| P/L / Initial Price
| Symbol
| YTD P/L / Initial Price
| Symbol
| YTD P/L/ Initial Price
| INZY
| 28.6%
| NAUT
| -41.7%
| INZY
| 338.1%
| AVTX
| -97.6%
| SCLP.L
| 24.6%
| STTK
| -23.5%
| PRVB
| 136.5%
| APTA.L
| -97.4%
| MRTX
| 17.5%
| GMDA
| -22.2%
| MOR
| 109.5%
| PTEIQ
| -87.2%
| BLCM
| 13.8%
| PHAT
| -22.0%
| ISEE
| 86.8%
| TCON
| -85.4%
| ICVX
| 10.2%
| RVNC
| -20.5%
| CRVS
| 80.0%
| ALT
| -84.1%
| Average and Median Portfolio Performance
|
| Recent P/L
|
|
|
| YTD P/L
|
|
|
| Avg.
| Median
|
|
|
| Avg
| Median
|
|
|
| -$5,427.23
| -$5,847.98
| BLADERUNNER
|
| -$17,601.73
| -$23,719.78
| ARTHUR RADLEY
| Top Seven Portfolio Performances
| Top Recent Performers
| Top YTD Performers
| Contestant (Prev. Rank)
| Recent P/L
| P/L vs. ^SPSIBI
| YTD P/L (Rank)
| Contestant (Prev. Rank)
| YTD P/L
| vs. Top Portfolio
| P/L vs. ^SPSIBI
| Rec. P/L (Rank)
| 1 - A.J. MULLEN (8)
| $536.58
| $5,564.00
| -$11,938.43 (6)
| 1 - ALONER (1)
| $22,917.38
| ——
| $35,022.75
| -$4,216.67 (6)
| 2 - RAJU_BIJLEE (5)
| -$805.98
| $4,221.45
| -$43,766.48 (14)
| 2 - ERIKOTTO (3)
| $17,862.93
| $5,054.45
| $29,968.30
| -$981.86 (3)
| 3 - ERIKOTTO (11)
| -$981.86
| $4,045.57
| $17,862.93 (2)
| 3 - RKRW (2)
| $10,795.27
| $12,122.11
| $22,900.64
| -$8,853.42 (13)
| 4 - BMAZ001 (3)
| -$2,958.01
| $2,069.41
| -$54,425.16 (15)
| 4 - STEVE LOKNESS (4)
| $7,947.81
| $14,969.57
| $20,053.18
| -$9,262.79 (14)
| 5 - GENEGURU (10)
| -$4,142.13
| $885.29
| -$36,222.89 (13)
| 5 - BLADERUNNER (5)
| -$7,510.99
| $30,428.37
| $4,594.38
| -$5,847.98 (8)
| 6 - ALONER (13)
| -$4,216.67
| $810.75
| $22,917.38 (1)
| 6 - A.J. MULLEN (6)
| -$11,938.43
| $34,855.81
| $166.95
| $536.58 (1)
| 7 - ARTHUR RADLEY (12)
| -$5,279.12
| -$251.70
| -$23,719.78 (8)
| 7 - TOMATO (7)
| -$20,415.85
| $43,333.23
| -$8,310.48
| -$6,374.65 (9)
| Top Portfolios’ Contents
| Top Recent Performance Portfolio (A.J. MULLEN)
| Top YTD Performance Portfolio (ALONER)
| Symbol (Rank)
| Current Allocation
| Value/Total | ROI
| YTD Stock P/L
| Recent StockP/L
| % Current Price Changefor $1,000 P/L
| Symbol (Rank)
| Initial Allocation
| Value/Total | ROI
| YTD Stock P/L
| Recent StockP/L
| % Current Price Changefor $1,000 P/L
| MRTX
| 12.5%
| 12.8% | -9.5%
| -$1,189.03
| $2,193.22
| 8.8%
| AFMD
| 10%
| 4.1% | -59.8%
| -$7,553.15
| -$510.78
| 19.7%
| NBIX
| 12.5%
| 13.5% | -4.8%
| -$596.53
| $135.01
| 8.4%
| CDTX
| 10%
| 13.1% | 27.2%
| $3,436.17
| -$787.46
| 6.2%
| ONT.L
| 12.5%
| 12.6% | -11.0%
| -$1,381.16
| -$464.30
| 9.0%
| CLSD
| 10%
| 8.0% | -21.7%
| -$2,734.81
| $401.53
| 10.1%
| PACB
| 12.5%
| 15.5% | 9.3%
| $1,161.37
| -$2,261.61
| 7.3%
| CRDF
| 10%
| 11.6% | 13.3%
| $1,674.04
| -$1,065.99
| 7.0%
| SCLP.L
| 12.5%
| 9.4% | -33.5%
| -$4,186.87
| $3,069.34
| 12.0%
| CRIS
| 10%
| 7.9% | -23.3%
| -$2,938.46
| -$806.56
| 10.3%
| TDOC
| 12.5%
| 11.3% | -20.6%
| -$2,574.00
| -$1,279.07
| 10.1%
| CRVS
| 10%
| 17.5% | 70.5%
| $8,899.05
| -$703.50
| 4.6%
| TWST
| 12.5%
| 12.1% | -14.6%
| -$1,821.71
| -$320.24
| 9.4%
| KZIA
| 10%
| 15.2% | 48.4%
| $6,113.02
| $363.90
| 5.3%
| XENE
| 12.5%
| 12.7% | -10.8%
| -$1,350.49
| -$535.76
| 9.0%
| MGTA
| 10%
| 16.3% | 58.7%
| $7,410.67
| $0.00
| 5.0%
|
|
|
|
|
|
| MRNA
| 10%
| 6.2% | -39.9%
| -$5,041.00
| -$1,107.81
| 13.2%
|
|
|
|
|
|
| PRVB
| 10%
| 0.0% | 136.5%
| $13,651.84
| $0.00
| --
|
|
